Posted in Regulatory Lilly bags FDA okay for Wegovy pill rival orforglipron April 1, 2026 Pharmaphorum Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk’s first-to-market Wegovy pill. RegulatoryMetabolic & GLP-1Read full story